CLINICARD PHOSPHORUS— 510(k) K760030

Substantially Equivalent

Harleco

FDA 510(k) clearance K760030 for CLINICARD PHOSPHORUS, Substantially Equivalent on 1976-09-13. Applicant: Harleco. Device class: 1.

Clearance details

Applicant: Harleco
Product code: Code CEO
Device class: Class 1
Regulation: 21 CFR 862.1580
Advisory panel: Clinical Chemistry
Date received: 1976-06-14
Decision date: 1976-09-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEO

K100263 — ELITECH CLINICAL SYSTEMS PHOSPHORUS, URIC ACID MONO SL AND UREA UV SL REAGENTS2011-05-06
K072141 — S40 CLINICAL ANALYZER, S TEST IP, S TEST UA2008-06-24
K041643 — SYNCHRON SYSTEMS PHOSPHORUS (PHS) REAGENT2004-08-18
K030015 — ATAC PAK PHOSPHORUS REAGENT2003-03-07
K022312 — PICCOLO PHOSPHORUS TEST SYSTEM2002-09-05

More clearances from Harleco

K820233 — ULTRAZYME PLUS GAMMA GT(65055-65056)1982-02-12
K813427 — ULTRACHEM GLUC-DH1981-12-31
K813038 — ULTRACHEM TP, ITEM #649741981-11-10
K813039 — ULTRACHEM E-CHOL, ITEM #650251981-11-10
K813040 — ULTRACHEM CA, ITEM #649751981-11-10

Data sourced from openFDA. This site is unofficial and independent of the FDA.